Related Experiment Videos
Inhibition of cardiac ATP-dependent potassium channels by sulfonylurea drugs
1Aventis Pharma Deutschland GmbH, DG Cardiovascular Diseases, Frankfurt/Main, Germany. heinz.goegelein@aventis.com
Current Opinion in Investigational Drugs (London, England : 2000)
|August 31, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Inhibitors of ATP-sensitive potassium channels in guinea pig isolated ischemic hearts.
Naunyn-Schmiedeberg's archives of pharmacology·2004
Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
Naunyn-Schmiedeberg's archives of pharmacology·2001
Effects of the cardioselective KATP channel blocker HMR 1098 on cardiac function in isolated perfused working rat hearts and in anesthetized rats during ischemia and reperfusion.
Naunyn-Schmiedeberg's archives of pharmacology·2001
Inhibition of IKs channels by HMR 1556.
Naunyn-Schmiedeberg's archives of pharmacology·2001
The K(ATP) channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbits.
Naunyn-Schmiedeberg's archives of pharmacology·2000
Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?
Current opinion in investigational drugs (London, England : 2000)·2011
Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.
Current opinion in investigational drugs (London, England : 2000)·2010
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.
Current opinion in investigational drugs (London, England : 2000)·2010
Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.
Current opinion in investigational drugs (London, England : 2000)·2010
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.
Current opinion in investigational drugs (London, England : 2000)·2010
Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.
Current opinion in investigational drugs (London, England : 2000)·2010
[Pharmacological management of pain in chronic wounds and stomas in adult patients].
Revista medica del Instituto Mexicano del Seguro Social·2026
Combination Therapy of Salbutamol and Spirulina: A Novel Dual-Action Approach for Asthma Management.
Mini reviews in medicinal chemistry·2026
Psychiatric Association of Türkiye Mood Disorders Section Depression Treatment Guideline - III: Treatment Approach for Depression Subtypes and Special Groups, Psychotherapies, and Psychosocial Interventions.
Turk psikiyatri dergisi = Turkish journal of psychiatry·2026
The emerging role of PDE4 inhibitors for the treatment of pulmonary fibrosis.
Expert review of clinical pharmacology·2026